About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Chairman Resignation

May 12, 2015

Click here to read more

Post navigation

2014 Annual Report

Oxymorphone Patch Program Update

Related Posts

Investor Presentation April 2018

April 17, 2018

Phosphagenics Notice of Annual General Meeting

April 28, 2017

Avecho reaches two-year stability milestone for its CBD softgel capsule

June 22, 2023June 22, 2023

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.